Unveiling the Mystery of Axial Spondyloarthritis: From Recognizing Signs to Exploring Treatment Options for Chronic Back
World AS Day 2024 Puts Focus on Early Diagnosis and Symptoms Recognition
World Ankylosing Spondylitis (AS) Day 2024 and the crucial theme it brings to the spotlight. This year, the theme is all about “Signs and Symptoms”, emphasizing the importance of early recognition and diagnosis of axSpA.
Did you know that, on average, it takes a whopping seven years from the onset of symptoms for individuals to receive an axSpA diagnosis? That’s a long time to be in the dark about a condition that can greatly impact one’s quality of life. Symptoms of axSpA range from back pain and fatigue to stiffness, along with related issues like uveitis and psoriasis.
But fear not! Companies like UCB are stepping up to the plate, reaffirming their commitment to supporting individuals with axSpA. By teaming up with organizations such as ASIF and NASS, they are working tirelessly to reduce diagnostic delays globally. Their mission? To empower patients to recognize symptoms early on, communicate effectively with healthcare providers, and ultimately, improve disease management.
UCB is rolling out some impressive initiatives to achieve these goals. The FASTRAX program, for instance, is harnessing new technologies to educate healthcare providers and enhance access to specialized rheumatology care. Meanwhile, the Rheumacensus program is zeroing in on identifying unmet care needs for axSpA patients in Europe.
And that’s not all – UCB is collaborating closely with healthcare providers to develop valuable medical education resources like the RheuMuseum and UCB Med Hub. Their dedication to serving the axSpA community through research, awareness campaigns, and amplifying patient voices is truly commendable.
Ankylosing Spondylitis, often dubbed as a “youngster’s disease”, typically strikes individuals between the ages of 17 and 45, with most cases cropping up in the 20s and 30s. The initial symptoms of AS, such as back pain, spine stiffness, eye redness, and digestive issues, are often brushed aside or misunderstood.
AS is no walk in the park – it’s an autoimmune disease triggered by a gene mutation that sparks inflammation in the spine joints, potentially leading to fused joints (a condition known as Ankylosis). While there’s no cure for AS, a combination of pharmacological and non-pharmacological therapies can help manage symptoms effectively.
Screening for AS often involves an MRI of the sacroiliac joint, with males being three times more likely to be affected than females. So, it’s crucial to stay vigilant, recognize the signs, and seek timely medical attention if you suspect you may have axSpA.
Stay informed, stay empowered, and here’s to raising awareness and promoting early diagnosis on World AS Day 2024! 🌟🔍🩺
Read also :Hamida Banu: The Empress who shaped Mughal History
